Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Qianjiang Yong'an Pharmaceutical Co., Ltd. was established in 2001 and is located in the National High tech Industrial Development Zone of Qianjiang City in the hinterland of the Jianghan Plain. It covers an area of over 500 acres and has a registered capital of 294 million six hundred and eighty-two thousand five hundred yuan. It is a national high-tech enterprise with independent intellectual property rights. The company's shares were listed on the Shenzhen Stock Exchange on March 5, 2010 (stock code 002365). The company has strong technological development capabilities and is an innovative enterprise and a demonstration enterprise for intellectual property construction in Hubei Province. The company's research and development platforms have been recognized as provincial-level enterprise technology centers and Hubei functional food additive engineering technology research centers. After years of development, the company has formed an overall pattern with the production and sales of food and drug additive taurine as the main body, and the production and sales of ethylene oxide and water reducing agent related products and health products are extended upstream and downstream. The company's independently created production process of taurine "ethylene oxide" has been awarded the "Torch Plan" certificate by the Ministry of Science and Technology of China. The company has a comprehensive quality control system and has passed certifications such as GMP, ISO9001, ISO22000, BRC, and FAMI-QS. It has also obtained the KOSHER certificate issued by the US OU and the HALAL certificate issued by the International Islamic Organization. 80% of the company's taurine products are exported to various parts of the world and are important suppliers to world-class companies such as Red Bull, Nestle, and Coca Cola. In 2017, the newly built 30000 ton/year taurine food additive project is highly in line with the "Made in China 2025" development strategy, deeply integrating the latest technological achievements, and achieving separate automation and overall intelligence in the entire process of taurine synthesis, crystallization purification, packaging, storage and transportation. It has achieved deep information perception, intelligent optimization, decision-making, and precise control, improving production efficiency and product quality. At present, the company's taurine production capacity has reached an annual output of 58000 tons, and its production and manufacturing have been comprehensively upgraded. The company has an annual production unit of 40000 tons of ethylene oxide, using the alcohol process of SD Company in the United States, supplemented by ethylene production, effectively avoiding the risk of price fluctuations in a single raw material. In the first half of 2019, Hubei Ling'an Technology Co., Ltd., a subsidiary of the company, completed the construction of the "112000 tons/year low-carbon epoxy derived fine chemical new materials" project and successfully put it into operation, forming a good synergistic effect with the production of ethylene oxide. The wholly-owned subsidiary Yongan Kangjian Pharmaceutical (Wuhan) Co., Ltd. has established a comprehensive "YATEK" product research and development system, which involves multiple key technical aspects such as functional factor screening, formulation, transportation, and evaluation in product research and development. It adopts various advanced patented modular formulation technologies to maximize the efficiency of functional dietary nutrition product development. By continuously strengthening business cooperation with Canada's top healthcare brand, Jianmeisheng, actively grafting international resources, achieving complementary advantages, and gradually forming a comprehensive development pattern of "Chinese capital+overseas brands". The company regards environmental protection as a priority element for development, and is willing to invest in environmental protection. It has improved smoke control, sewage separation, and equipped various environmental monitoring facilities, achieving significant results, and steadily meeting the discharge standards of various pollutants. Efforts will be made to build a garden style factory, with a greening rate of over 30% in the factory area. Pay attention to improving the production and living conditions of employees, equipping them with commuting cars, providing free work meals, building employee apartments, organizing celebrations and various cultural and sports activities, arranging employee travel and annual physical examinations, providing traditional holiday benefits and competitive compensation. Enterprise party organizations and mass organizations actively take action to jointly build a harmonious enterprise. Over the years, the company has been rated as "Advanced Industrial Enterprise in Hubei Province", "Top 10 Pharmaceutical Industry Enterprises in Hubei Province", "Harmonious Labor Relations Enterprise in Hubei Province", "exemplary organization in Science and Technology Work", "Top 10 Honest Enterprise", etc. by provincial and municipal governments and functional departments, and has won various honorary titles such as "Charity and Love Enterprise", "Home of Model Workers", "Red Flag Unit", etc. The company will continue to be committed to technological improvement and innovation, leveraging the power of the capital market engine to further improve the company's industrial chain, with the mission of "working for human health", and strive to build the company into an outstanding human health promoter in the world.
Headquarter Qianjiang
Establish Date 6/18/2001
Listed Code 002365.SZ
Listed Date 3/5/2010
Chairman Chen Yong.
CEO Hong Rengui.
Website www.chinataurine.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial